Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver Grafting”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02853981
What this trial is testing

Clamp-crush Technique Versus Harmonic Scalpel in Living Donor Hepatectomy

Who this might be right for
Hepatic Transplantation
Mansoura University 72
Not applicableUnknownNCT05588271
What this trial is testing

A New Prediction Mode for Predicting the Risk of Pressure Injury in Patients Undergoing Liver Transplantation

Who this might be right for
Liver Transplantation
RenJi Hospital 1,200
Not applicableStudy completedNCT02352181
What this trial is testing

Management of Coagulopathy During Orthotopic Liver Transplantation. Comparison Between ROTEM-based Management and Standard Biological Assessment.

Who this might be right for
Liver Transplantation
Hospices Civils de Lyon 82
Not applicableUnknownNCT04865471
What this trial is testing

Resection And Partial Liver Segmental Transplantation With Delayed Total Hepatectomy

Who this might be right for
Liver Metastases
Azienda Ospedaliera di Padova 18
Not applicableStudy completedNCT02990351
What this trial is testing

Efficacy of Loco-regional Treatment for Hepatocellular Carcinoma Prior to Living Donor Liver Transplantation in Egypt

Who this might be right for
Hepatocellular Carcinoma (HCC)Living Donor Liver Transplantation
Ain Shams University 29
Not applicableUnknownNCT03814772
What this trial is testing

To Establish a Blood Transfusion Prediction Model for Liver Transplantation Patients Based on PBM

Who this might be right for
Blood Transfusion Complication
The Third Xiangya Hospital of Central South University 2,000
Not applicableStudy completedNCT05532592
What this trial is testing

Investigation on the Hesitancy of COVID-19 Vaccination Among Liver Transplant Recipients in China

Who this might be right for
Vaccine Hesitancy
RenJi Hospital 449
Not applicableStudy completedNCT04618692
What this trial is testing

Biliary Anastomosis Using Surgical Loupe Versus Microscope in Living Donor Liver Transplantation

Who this might be right for
Liver FailureLiver DiseasesLiver Cancer+2 more
Istanbul Medipol University Hospital 52
Early research (Phase 1)Study completedNCT01888302
What this trial is testing

Sirolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients At High Risk for Cholangiocarcinoma Recurrence After Liver Transplant or Surgery

Who this might be right for
Hepatic Complication
Mayo Clinic 1
Not applicableUnknownNCT04621812
What this trial is testing

Role of Fecal Microbiota in Predicting Graft Rejection and Sepsis Among Recipients of Living Donor Liver Transplant in First Year.

Who this might be right for
Acute Liver FailureAcute-On-Chronic Liver FailureLiver Cirrhosis
Institute of Liver and Biliary Sciences, India 100
Large-scale testing (Phase 3)Looking for participantsNCT03394365
What this trial is testing

Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy

Who this might be right for
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD)Solid Organ Transplant ComplicationsLymphoproliferative Disorders+2 more
Pierre Fabre Medicament
Not applicableEnrolling By InvitationNCT07744230
What this trial is testing

Prometheus: Prophylactic Mesh After OLtx for Hernia Reduction Study.

Who this might be right for
Incisional Hernia/Prevention and Control
University of Rome Tor Vergata 100
Post-approval studies (Phase 4)Study completedNCT00821587
What this trial is testing

Cyclosporine in Hepatitis C Infection Viral Clearance Following Liver Transplantation

Who this might be right for
Hepatitis C
University of Florida 39
Not applicableStudy completedNCT00857844
What this trial is testing

Genetic Predisposition-Chronic Nephrotoxicity From CI-Liver Transplant Recipients-Potential Correlation-Urinary Biomarkers

Who this might be right for
Complication of Transplanted Liver
Northwestern University 207
Testing effectiveness (Phase 2)Study completedNCT01146808
What this trial is testing

Adefovir Plus Vaccination in Transplant Patients Without Hepatitis B That Receive a Core Antibody Positive Liver

Who this might be right for
Hepatitis BLiver Transplantation
Columbia University 16
Testing effectiveness (Phase 2)Study completedNCT02981602
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Antiviral Activity of IONIS-HBVRx in Treatment-Naïve Patients With Chronic HBV Infection

Who this might be right for
Hepatitis BChronic Hepatitis B Atypical
GlaxoSmithKline 31
Not applicableStudy completedNCT04067739
What this trial is testing

ICU Readmission in Adult Egyptian Patients Undergoing Living Donor Liver Transplant

Who this might be right for
ICU Readmission
Ain Shams University 299
Not applicableStudy completedNCT05625139
What this trial is testing

Implementation of an Enhanced Rehabilitation Protocol After Liver Transplantation: Feasibility and Analysis of Results

Who this might be right for
Liver Transplant Disorder
University Hospital, Strasbourg, France 34
Not applicableLooking for participantsNCT07480057
What this trial is testing

Assessment of Changes in Bone Mineral Metabolism After Liver Transplantation by Bone Mineral Densitometry

Who this might be right for
Chronic Liver Disease and ACLF
Institute of Liver and Biliary Sciences, India 100
Large-scale testing (Phase 3)Ended earlyNCT02478229
What this trial is testing

Early Treatment With Sofosbuvir (SOF) and Ledipasvir (LDV) to Prevent HCV Recurrence After Liver Transplantation (OLT)

Who this might be right for
Hepatitis C Viral Infection
University Health Network, Toronto 1
Next Page
115